US Patent 11168322 CRISPR RNA targeting enzymes and systems and uses thereof

Patent 11168322 was granted and assigned to Arbor Biotechnologies on November, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Arbor Biotechnologies

Current Assignee

Arbor Biotechnologies

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11168322

Date of Patent

November 9, 2021

Patent Application Number

20180308

Date Filed

March 8, 2018

Patent Primary Examiner

‌

Channing S Mahatan

Patent abstract

The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of a nucleic acid.